These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 190173)
1. Detection of Epstein-Barr virus early antigen-D and its antibodies by passive hemagglutination. Ogburn CA; Zajac BA Int J Cancer; 1977 Feb; 19(2):150-60. PubMed ID: 190173 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus early antigen titer by immunofluorescence in microplates. A new semi-automated method based on microtiter system. Favart AM; Lamy ME; Allemeersch D; Burtonboy G; Vanoverschelde J Med Microbiol Immunol; 1978 Nov; 166(1-4):209-17. PubMed ID: 214682 [TBL] [Abstract][Full Text] [Related]
3. A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens. Luka J; Chase RC; Pearson GR J Immunol Methods; 1984 Feb; 67(1):145-56. PubMed ID: 6321599 [TBL] [Abstract][Full Text] [Related]
4. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
5. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma. Liu MT; Lin LS; Yu Y; Chung TT; Hsu CY; Chen JT; Jeng KC Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):7-15. PubMed ID: 8820030 [TBL] [Abstract][Full Text] [Related]
6. Detection of Epstein-Barr virus antigens with enzyme-conjugated antibody. Granlund DJ; Andrese AP Int J Cancer; 1977 Oct; 20(4):495-9. PubMed ID: 72045 [TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen. Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Henle G; Henle W Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests. Lenoir G; Berthelon MC; Favre MC; De-Thé G Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116 [TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay. Hopkins RF; Witmer TJ; Neubauer RH; Rabin H J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease. Bardy B; Morinet F; Pérol Y Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus. Yang CS; Hewetson JF Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526 [No Abstract] [Full Text] [Related]
14. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Gerber P; Lucas S Proc Soc Exp Biol Med; 1972 Nov; 141(2):431-8. PubMed ID: 4344263 [No Abstract] [Full Text] [Related]
16. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections. Cevenini R; Donati M; Rumpianesi F; Moroni A; Paolucci P J Clin Pathol; 1984 Apr; 37(4):440-3. PubMed ID: 6323549 [TBL] [Abstract][Full Text] [Related]
17. The role of Epstein-Barr virus (EBV) in various human disorders. Hewetson JF South Med J; 1975 Oct; 68(10):1271-3. PubMed ID: 170689 [No Abstract] [Full Text] [Related]
18. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. Edson CM; Cohen LK; Henle W; Strominger JL J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181 [TBL] [Abstract][Full Text] [Related]
19. A novel early antigen associated with Epstein-Barr virus productive cycle. Freemer CS; Bertoni G; Takagi S; Sairenji T Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883 [TBL] [Abstract][Full Text] [Related]
20. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]